| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V75339 | [Ala2] Endothelin-3, human | 2243207-08-9 | [Ala2] Endothelin-3, human is a linear analog of endothelin ET-3 in which Ala replaces the Cys residue. |
|
V75335 | ANP (1-30), frog | 309245-16-7 | ANP (1-30), frog is a polypeptide fragment of frog-derived atrial peptide. |
|
V110580 | Big endothelin-3 (Human, 1-41 amide) | 133551-97-0 | Large endothelin-3 (human, 1-41 amide) is a precursor molecule of the endothelin-3 (ET-3) peptide, consisting of 41 amino acids. |
|
V115628 | BQ-610 | 141595-53-1 | BQ-610 is a selective endothelin A receptor (ETA receptor) antagonist. |
|
V79302 | Endothelin 1 (swine, human), Alexa Fluor 488-labeled | Endothelin 1 (swine, human), Alexa Fluor 488-labeled is a synthetic peptide of Endothelin 1 labeled with 488 fluorescence. | |
|
V138080 | IRL-1620 TFA | IRL-1620 TFA is a potent and selective endothelin receptor type B (ETB) agonist with a Ki value of 16 pM. | |
|
V85693 | PD 156252 | 175592-65-1 | |
|
V81357 | Sarafotoxin S6a TFA | Sarafotoxin S6a TFA is a Sarafotoxin analogue and an endothelin receptor agonist/activator with similar ETA/ETB selectivity to Endothelin-3. | |
|
V145424 | Sulfatroxazole-d4 | Sulfatroxazole-d4 is a deuterated sulfatrazazole (9). | |
|
V1511 | Sitaxentan sodium (Sitaxsentan; IPI 1040) | 210421-74-2 | Sitaxentan sodium (formerly IPI-1040; TBC-11251; IPI 1040; TBC11251; Thelin), the sodium salt ofSitaxentan, is a selective and orally bioavailable endothelin A receptor (ETA) antagonist with anti-hypertensive activity. |
|
V1512 | Ambrisentan (BSF 208075; LU 208075) | 177036-94-1 | Ambrisentan (formerly BSF-208075; LU-208075; BSF208075; LU208075; Letairis; Volibris; pulmonext) is a selective antagonist of the endothelin-1 type A receptor (ETA). |
|
V1513 | Bosentan | 147536-97-8 | Bosentan (formerly Ro 47-0203; brand name Tracleer) is a potent, competitive and dual antagonist of endothelin (ET) receptor with anti-hypertensive activity. |
|
V1509 | Bosentan Hydrate (Ro 47-0203) | 157212-55-0 | Bosentan Hydrate (also known as Ro 47-0203; Ro47-0203; Ro-47-0203; Tracleer) is a potent, competitive and dual endothelin (ET) A/B receptor antagonist for ET-A and ET-B with anti-hypertensive activity. |
|
V1514 | BQ-123 | 136553-81-6 | BQ-123 (Cyclo(D-trp-D-asp-pro-D-val-leu); BQ123; BQ 123) is a potent andselective antagonist of endothelin A receptor (ETAR) with an IC50 of 7.3 nM. |
|
V4422 | Atrasentan HCl | 195733-43-8 | Atrasentan HCl, the hydrochloride salt of Atrasentan (NSC-720763; ABT-627; A-147627; trade name: Xinlay), is a novel and selective endothelin receptor antagonist (IC50 = 0.0551 nM for ETA) with anticancer activity. |
|
V1510 | Macitentan (ACT-064992 D4) | 441798-33-0 | Macitentan (formerly ACT-064992; ACT064992; ACT 064992; Opsumit) is an orally bioavailable and non-peptide, dual antagonist of ETA/ETB endothelin (ET) receptor. |
|
V1508 | Zibotentan (ZD4054) | 186497-07-4 | Zibotentan (formerly known as ZD-4054; ZD4054) is a specific and orally bioavailable Endothelin (ET)A antagonist with potential antitumor activity. |